Silicon Drugs & Intermediates Private Limited
U24100TG2011PTC072926ActivePrivateUnlisted
Last updated: 2026-06-07
30
Compliance Health · F
3 / 9 signals passed
Silicon Drugs & Intermediates Private Limited is a Private Indian company incorporated in 2011 and based in Telangana, India. Silicon Drugs & Intermediates Private Limited operates in Pharmaceuticals & Chemicals (NIC 24100) with authorized capital of —. RegisterKaro's Compliance Health Score for the company is 30/100 (grade F), reflecting a weak compliance posture.
Risk FlagsFinancials not yet extracted · awaiting AOC-4 XBRLDirectors not yet extracted · awaiting MGT-7Health F · 30/100
Revenue (latest FY)
—
Awaiting extraction
PAT (latest FY)
—
Awaiting extraction
Open Charges
0
No encumbrances
Active Directors
0
No resignations
Paid-up Capital
—
—
Filings on Record
0
All current
Incorporated
2011
15 years old
State
Telangana
Sector
Pharmaceuticals & Chemicals
NIC 24100
Class
Private
Sub-category
—
Authorized Capital
—
Paid-up Capital
—
Members
—
Last AGM
—
Last Balance Sheet
—
Latest Filing
—
Registered Email
—
Registered Office
—
SILICON DRUGS & INTERMEDIATES PRIVATE LIMITEDTRACXN · PUBLIC DATA
Brand SILICON DRUGS & INTERMEDIATES PRIVATE LIMITED · Legal entity Silicon Drugs & Intermediates Private Limited
Total Funding
Latest Round
—
Revenue
Valuation
Funding Rounds
—
Employees
—
Stage
—
HQ
—
Founded
2011
Source: Tracxn (public profile) · joined to MCA on CIN U24100TG2011PTC072926
Quick facts
Registered office
—
NIC code
24100
Statutory auditor
Awaiting ADT-1 / AOC-4 extraction
Registered email
—
Section
Pharmaceuticals & Chemicals
ROC
—
Website
Class · sub-category
Private
Incorporation · Last AGM
— · —
Directors
LockedSI
Suresh Iyer
Managing Director5.2y · Ahmedabad · DIN 4994773
VS
Vikram Singh Rathore
Managing Director2.0y · Mumbai · DIN 1546646
Get the full board of directors
Directors, DINs & appointment history for Silicon Drugs & Intermediates Private Limited.
What you'll get
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | 0d | filed |
| MGT-7 | FY2024-25 | 25 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | 0d | filed |
| MGT-7 | FY2023-24 | 20 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | +36d | filed |
| MGT-7 | FY2022-23 | 25 Nov 2022 | 29 Nov 2022 | 0d | filed |
Get financial statements & other filing documents
Full MCA filing history for Silicon Drugs & Intermediates Private Limited.
What you'll get
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 688628962 | State Bank of India(Bank) | ₹16.33 Cr | 04 Jul 2021 | Open |
| 471323133 | Axis Bank Ltd(Bank) | ₹8.49 Cr | 27 Jan 2021 | Open |
| 678482898 | Axis Bank Ltd(Bank) | ₹13.47 Cr | 27 Jan 2019 | Open |
| 294376983 | HDFC Bank Ltd(Bank) | ₹9.16 Cr | 04 Jul 2022 | Satisfied |
See registered charges & lenders
Charge IDs, lenders & amounts for Silicon Drugs & Intermediates Private Limited.
What you'll get
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
Locked| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| FY2024-25 | ₹81.12 Cr | ₹8.58 Cr | ₹60.07 Cr | ₹96.62 Cr | 285 |
| FY2023-24 | ₹71.68 Cr | ₹7.94 Cr | ₹46.27 Cr | ₹71.16 Cr | 30 |
| FY2022-23 | ₹63.53 Cr | ₹6.36 Cr | ₹33.30 Cr | ₹65.23 Cr | 179 |
| FY2021-22 | ₹62.29 Cr | ₹5.92 Cr | ₹59.74 Cr | ₹104.22 Cr | 197 |
Gain deeper financial insights of this entity
Audited financials & ratios for Silicon Drugs & Intermediates Private Limited.
What you'll get
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Detailed Financials
Locked| Line item | FY2024-25 | FY2023-24 | FY2022-23 | FY2021-22 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ₹81.12 Cr | ₹71.68 Cr | ₹63.53 Cr | ₹62.29 Cr |
| Other income | ₹52.47 L | ₹1.18 Cr | ₹95.48 L | ₹1.01 Cr |
| Total income | ₹81.65 Cr | ₹72.86 Cr | ₹64.48 Cr | ₹63.31 Cr |
| Total expenses | ₹70.67 Cr | ₹62.70 Cr | ₹56.34 Cr | ₹55.73 Cr |
| Profit before tax | ₹11.15 Cr | ₹10.32 Cr | ₹8.27 Cr | ₹7.69 Cr |
| Profit / (Loss) after tax | ₹8.58 Cr | ₹7.94 Cr | ₹6.36 Cr | ₹5.92 Cr |
| Balance sheet | ||||
| Equity / Net worth | ₹60.07 Cr | ₹46.27 Cr | ₹33.30 Cr | ₹59.74 Cr |
| Borrowings | ₹9.88 Cr | ₹5.67 Cr | ₹17.45 Cr | ₹23.58 Cr |
| Current liabilities | ₹17.46 Cr | ₹8.00 Cr | ₹17.34 Cr | ₹15.09 Cr |
| Total liabilities | ₹36.55 Cr | ₹24.89 Cr | ₹31.92 Cr | ₹44.48 Cr |
| Current assets | ₹44.96 Cr | ₹26.08 Cr | ₹31.68 Cr | ₹57.68 Cr |
| Cash & equivalents | ₹11.94 Cr | ₹3.33 Cr | ₹6.08 Cr | ₹17.71 Cr |
| Total assets | ₹96.62 Cr | ₹71.16 Cr | ₹65.23 Cr | ₹104.22 Cr |
| Employees | 285 | 30 | 179 | 197 |
Gain deeper financial insights of this entity
Audited financials & ratios for Silicon Drugs & Intermediates Private Limited.
What you'll get
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Compounded Annual Growth Rate
Locked| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue | ₹81.12 Cr | +33.0% | +10.0% | -1.7% |
| Profit after Tax | ₹8.58 Cr | +15.4% | +7.6% | +9.5% |
| Net Worth | ₹60.07 Cr | -4.0% | +27.7% | +21.6% |
| Employees | 285 | -1.7% | +11.4% | +14.0% |
Gain deeper financial insights of this entity
Audited financials & ratios for Silicon Drugs & Intermediates Private Limited.
What you'll get
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Financial Ratios
Locked| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| FY2024-25 | ₹81.12 Cr | ₹8.58 Cr | +10.57% | +12.71% | +14.28% | +8.88% | 0.16 | ₹28.46 L |
| FY2023-24 | ₹71.68 Cr | ₹7.94 Cr | +11.07% | +14.51% | +17.15% | +11.15% | 0.12 | ₹2.39 Cr |
| FY2022-23 | ₹63.53 Cr | ₹6.36 Cr | +10.02% | +17.43% | +19.11% | +9.76% | 0.52 | ₹35.49 L |
| FY2021-22 | ₹62.29 Cr | ₹5.92 Cr | +9.50% | -8.18% | +9.91% | +5.68% | 0.39 | ₹31.62 L |
Gain deeper financial insights of this entity
Audited financials & ratios for Silicon Drugs & Intermediates Private Limited.
What you'll get
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 4 | 3,93,23,410 | 80.54% |
| Institutional Investors | 2 | 31,41,006 | 6.43% |
| Public & Others | 24 | 63,58,204 | 13.02% |
See the full shareholding pattern
Promoter, institutional & public holding for Silicon Drugs & Intermediates Private Limited.
What you'll get
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
164 peersMetricThis companyCohort medianCohort P75Quartile
Revenue (latest FY)
—
PAT (latest FY)
—
Employees
—
—
—
—
Paid-up capital
—
Compliance Health
63
96
96
Bottom quartile · P2
External data sources
7 plannedGSTIN Registrations
GST portal
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
MSME-1 form
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
AOC-4 schedule
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
CRISIL / ICRA / CARE feeds
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
IP India Trademark Registry
Applied, registered, opposed. Class numbers + status.
Patents
IP India Patent Registry
Applications and grants. Inventor names + filing dates.
Legal Cases
eCourts + Indian Kanoon
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.
FAQs about Silicon Drugs & Intermediates Private Limited
When was Silicon Drugs & Intermediates Private Limited incorporated?
Silicon Drugs & Intermediates Private Limited was incorporated in 2011. Its CIN is U24100TG2011PTC072926 and it is registered with the relevant Registrar of Companies.
Where is Silicon Drugs & Intermediates Private Limited located?
Silicon Drugs & Intermediates Private Limited is headquartered in Telangana.
What sector does Silicon Drugs & Intermediates Private Limited operate in?
Silicon Drugs & Intermediates Private Limited operates in the Pharmaceuticals & Chemicals sector (NIC code 24100), classified as Indian Non-Govt Company.
Who are the directors of Silicon Drugs & Intermediates Private Limited?
Director details for Silicon Drugs & Intermediates Private Limited have not yet been extracted from MGT-7 filings.
What is the paid-up capital of Silicon Drugs & Intermediates Private Limited?
Silicon Drugs & Intermediates Private Limited has authorized capital of — and paid-up capital of —.
Does Silicon Drugs & Intermediates Private Limited have any open charges?
Silicon Drugs & Intermediates Private Limited has no open MCA-registered charges on record.
What is Silicon Drugs & Intermediates Private Limited's Compliance Health Score?
RegisterKaro's Compliance Health Score for Silicon Drugs & Intermediates Private Limited is 30/100 (grade F), based on 9 weighted signals across MCA filings, charges, directors, capital, and overall status. 3 of 9 signals passed.